Arsenic trioxide (As2O3) reduces the invasive and metastatic properties of cervical cancer cells in vitro and in vivo

Gynecologic Oncology - Tập 106 - Trang 400-406 - 2007
Jing Yu1, Haili Qian1, Yunfeng Li1, Yang Wang1, Xueyan Zhang1, Xiao Liang1, Ming Fu1, Chen Lin1
1State Key Laboratory of Molecular Oncology, Cancer Institute/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No.17 Panjiayuan Nanli, Chao Yang District, P.O. Box 2258, Beijing 100021, PR China

Tài liệu tham khảo

Cervical cancer, 1996, vol. 14, 1 Lazo, 1999, The molecular genetics of cervical carcinoma, Br J Cancer, 80, 2008, 10.1038/sj.bjc.6690635 zur Hausen, 1986, Intracellular surveillance of persisting viral infections. Human genital cancer results from deficient cellular control of papillomavirus gene expression, Lancet, 2, 489, 10.1016/S0140-6736(86)90360-0 zur Hausen, 1989, Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers, Cancer Res, 49, 4677 Uslu, 2000, Arsenic trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines, Clin Cancer Res, 6, 4957 Shen, 2000, The alteration of mitochondria is an early event of arsenic trioxide induced apoptosis in esophageal carcinoma cells, Int J Mol Med, 5, 155 Maeda, 2001, Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer, Cancer Res, 61, 5432 Zheng, 1999, Arsenic trioxide induces apoptosis of HPV16 DNA-immortalized human cervical epithelial cells and selectively inhibits viral gene expression, Int J Cancer, 82, 286, 10.1002/(SICI)1097-0215(19990719)82:2<286::AID-IJC21>3.0.CO;2-K Jing Yu, HQ, Yunfeng Li, Yang Wang, Xueyan Zhang, Xiao Liang, Ming Fu, Chen Lin. Therapeutic Effect of Arsenic Trioxide (As2O3) on Cervical Cancer in Vitro and in Vivo through Apoptosis Induction cancer biology and therapy 2007;6. Vleminckx, 1991, Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role, Cell, 66, 107, 10.1016/0092-8674(91)90143-M Williams, 2004, The caveolin proteins, Genome Biol, 5, 214, 10.1186/gb-2004-5-3-214 Capozza, 2003, Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation, Am J Pathol, 162, 2029, 10.1016/S0002-9440(10)64335-0 Park, 2002, Caveolin-1-deficient mice show accelerated mammary gland development during pregnancy, premature lactation, and hyperactivation of the Jak-2/STAT5a signaling cascade, Mol Biol Cell, 13, 3416, 10.1091/mbc.02-05-0071 Wei, 2005, Arsenic trioxide prevents radiation-enhanced tumor invasiveness and inhibits matrix metalloproteinase-9 through downregulation of nuclear factor kappaB, Oncogene, 24, 390, 10.1038/sj.onc.1208192 Li, 2003, Epstein–Barr virus latent membrane protein 1: structure and functions, J Biomed Sci, 10, 490, 10.1007/BF02256110 Rimm, 1995, Alpha 1(E)-catenin is an actin-binding and -bundling protein mediating the attachment of F-actin to the membrane adhesion complex, Proc Natl Acad Sci U S A, 92, 8813, 10.1073/pnas.92.19.8813 Vasioukhin, 2001, Actin dynamics and cell–cell adhesion in epithelia, Curr Opin Cell Biol, 13, 76, 10.1016/S0955-0674(00)00177-0 Morin, 1999, beta-Catenin signaling and cancer, BioEssays, 21, 1021, 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P Peifer, 2000, Wnt signaling in oncogenesis and embryogenesis-a look outside the nucleus, Science, 287, 1606, 10.1126/science.287.5458.1606 Bagnoli, 2000, Downmodulation of caveolin-1 expression in human ovarian carcinoma is directly related to alpha-folate receptor overexpression, Oncogene, 19, 4754, 10.1038/sj.onc.1203839 Bender, 2000, Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity, Cancer Res, 60, 5870 Wiechen, 2001, Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas, Am J Pathol, 158, 833, 10.1016/S0002-9440(10)64031-X Racine, 1999, Reduction of caveolin 1 gene expression in lung carcinoma cell lines, Biochem Biophys Res Commun, 255, 580, 10.1006/bbrc.1999.0236 Barnes, 1997, Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases, N Engl J Med, 336, 1066, 10.1056/NEJM199704103361506 Baldwin, 1996, The NF-kappa B and I kappa B proteins: new discoveries and insights, Annu Rev Immunol, 14, 649, 10.1146/annurev.immunol.14.1.649 Rossi, 2000, Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase, Nature, 403, 103, 10.1038/47520 Karin, 2000, Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity, Annu Rev Immunol, 18, 621, 10.1146/annurev.immunol.18.1.621 Kapahi, 2000, Inhibition of NF-kappa B activation by arsenite through reaction with a critical cysteine in the activation loop of Ikappa B kinase, J Biol Chem, 275, 36062, 10.1074/jbc.M007204200 Kuphal, 2004, Loss of E-cadherin leads to upregulation of NFkappaB activity in malignant melanoma, Oncogene, 23, 8509, 10.1038/sj.onc.1207831 Lo, 2004, Phenotypic alterations induced by the Hong Kong-prevalent Epstein–Barr virus-encoded LMP1 variant (2117-LMP1) in nasopharyngeal epithelial cells, Int J Cancer, 109, 919, 10.1002/ijc.20051